PMID: 3891617Jul 1, 1985Paper

Captopril potentiates chronotropic baroreflex responses to carotid stimuli in humans

T J Ebert


Angiotensin II is a potent vasoconstrictor and has profound effects on autonomic neural mechanisms in experimental animals. Human carotid baroreflex control of arterial pressure and heart period was examined before and after acutely decreasing angiotensin II levels by administering 50 mg of oral captopril, an angiotensin converting enzyme inhibitor. Carotid baroreceptor stimuli were delivered by a neck chamber worn by 14 normotensive volunteers. Four subjects received placebo. Arterial pressure responses to carotid distention and tachycardia in response to carotid compression were not changed in captopril or placebo groups; however, there was an augmented bradycardic response to carotid stretch in captopril-treated subjects. These results indicate that captopril has an asymmetrical effect on carotid baroreflex function and suggest that enhanced baroreflex mediated bradycardia is due to a reduction in central nervous system angiotensin II levels by captopril, which augments vagal-cardiac responses to carotid stimuli.


Dec 1, 1970·The American Journal of Physiology·C S Sweet, M J Brody
Mar 1, 1973·Japanese Heart Journal·K Fukiyama
Apr 1, 1972·Kidney International·J E SealeyJ H Laragh
May 1, 1974·European Journal of Pharmacology·B M GoldsteinM J Brody
Jan 1, 1983·Clinical and Experimental Hypertension. Part A, Theory and Practice·G A MacGregorJ J Morton
Dec 1, 1984·The American Journal of Physiology·T J EbertJ J Smith
Jul 16, 1982·European Journal of Pharmacology·A NakashimaC I Johnston
Apr 21, 1982·The American Journal of Cardiology·G ManciaA Zanchetti
Jun 1, 1980·The Journal of Clinical Investigation·S L SwartzT J Moore
Mar 1, 1981·Clinical and Experimental Pharmacology & Physiology·W B Lee, E R Lumbers
Jan 1, 1982·British Journal of Pharmacology·E K Potter


Feb 21, 2009·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Victoria L Cooper, Roger Hainsworth
Sep 1, 1992·Journal of the American College of Cardiology·D BonaduceM Condorelli
Oct 23, 1997·Journal of Cardiovascular Pharmacology·E MontemayorR Buñag
Aug 1, 1997·Australian and New Zealand Journal of Medicine·P Sleight
Oct 25, 1986·British Medical Journal·H JensenP Fruergaard
Apr 1, 1986·The Journal of Clinical Investigation·T J EbertM Skelton
Jan 1, 1988·Clinical and Experimental Hypertension. Part A, Theory and Practice·H MurataniK Fukiyama
Jan 1, 1987·Clinical and Experimental Hypertension. Part A, Theory and Practice·K TakedaH Ijichi
Jan 1, 1990·Clinical and Experimental Hypertension. Part A, Theory and Practice·H MurataniK Fukiyama
Mar 11, 1988·The American Journal of Medicine·P Sleight
Nov 1, 1990·American Heart Journal·K J OsterzielW Kübler
Mar 1, 1988·British Journal of Clinical Pharmacology·G B KondoweD W Harron
May 22, 2004·International Journal of Psychiatry in Medicine·Tien-Wen LeeJen-Ping Hwang
Oct 25, 1986·British Medical Journal·B H StrickerK van Wieringen
Oct 13, 2005·Expert Opinion on Pharmacotherapy·Anirban ChoudhuryGregory Y H Lip
May 8, 1999·The American Journal of Physiology·R BuñagB Allen
Jan 1, 1989·Pharmacotherapy·M R UjhelyiP H Vlasses

Related Concepts

Angiotensin II, Val(5)-
Diastolic Blood Pressure
Structure of Carotid Sinus
Drug Augmentation
Pulse Rate
Reflex Action

Related Feeds


Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.